Blog

Richard Lee: Key questions about clinical trial diversification at the Mass General Cancer Center Cancer Equity Colloquium

Collage Photo of Drs. Collin Weekes, Regina Brown, Luckson Mathieu and Erica Stringer-Reasor

Jun 21, 2024, 06:24

Richard Lee: Key questions about clinical trial diversification at the Mass General Cancer Center Cancer Equity Colloquium

Erica Stringer-Reasor, Vice Chairperson at The University of Alabama at Birmingham, shared a post by Richard Lee, Genitourinary medical oncologist at Mass General in Boston, on X:

“Thank you Dr. Colin Weekes and Mass General Cancer Center for inviting me to the Cancer Equity Colloquium to discuss the important topic of clinical trial diversification.”

The post by Richard Lee:

“Key questions about clinical trial diversification at the Mass General Cancer Center Cancer Equity Colloquium with Drs. Weekes, Brown, Mathieu, and Stringer-Reasor.”

Source: Erica Stringer-Reasor/X and Richard Lee/X

Brown cancer Cancer Equity Colloquium clinical trial diversification Colin Weekes Erica Stringer-Reasor Mass General Cancer Center Mathieu OncoDaily Oncology Richard Lee

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage